Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 2,405,186 | 2,282,449 | 2,200,378 | 2,121,660 | 2,137,253 |
| Cost of Goods | 617,345 | 580,931 | 584,447 | 531,989 | 533,863 |
| Gross Profit | 1,787,841 | 1,701,518 | 1,615,931 | 1,589,671 | 1,603,390 |
| Operating Expenses | 729,094 | 902,263 | 748,902 | 586,982 | 587,535 |
| Operating Income | 1,059,092 | 800,186 | 867,476 | 1,003,678 | 1,016,718 |
| Interest Expense | 88,418 | 97,270 | 74,998 | 43,097 | 46,107 |
| Other Income | -1,075 | -34,085 | 26,365 | 14,406 | 11,978 |
| Pre-tax Income | 969,599 | 668,831 | 818,843 | 974,987 | 982,589 |
| Income Tax | 263,525 | 231,300 | 157,084 | 237,449 | 240,130 |
| Net Income Continuous | 706,074 | 437,531 | 661,759 | 737,538 | 742,459 |
| Minority Interests | -5,490 | -4,425 | -3,386 | -3,586 | -3,768 |
| Net Income | $711,564 | $441,956 | $665,145 | $741,124 | $746,227 |
| EPS Basic Total Ops | 0.47 | 0.29 | 0.44 | 0.49 | 0.48 |
| EPS Basic Continuous Ops | 0.47 | 0.29 | 0.44 | 0.48 | 0.47 |
| EPS Diluted Total Ops | 0.46 | 0.28 | 0.43 | 0.48 | 0.47 |
| EPS Diluted Continuous Ops | 0.45 | 0.28 | 0.43 | 0.47 | 0.46 |
| EBITDA(a) | $1,126,504 | $866,353 | $940,901 | $1,076,679 | $1,091,610 |